Your browser doesn't support javascript.
loading
Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation
Mansur, Antonio de Padua; Takada, Julio Yoshio; Avakian, Solange Desiree; Strunz, Celia M.C..
Afiliação
  • Mansur, Antonio de Padua; Universidade de Sao Paulo. Faculdade de Medicina. Heart Institute. Sao Paulo. BR
  • Takada, Julio Yoshio; Universidade de Sao Paulo. Faculdade de Medicina. Heart Institute. Sao Paulo. BR
  • Avakian, Solange Desiree; Universidade de Sao Paulo. Faculdade de Medicina. Heart Institute. Sao Paulo. BR
  • Strunz, Celia M.C.; Universidade de Sao Paulo. Faculdade de Medicina. Heart Institute. Sao Paulo. BR
Clinics ; 67(6): 543-546, 2012. graf, tab
Artigo em Inglês | LILACS | ID: lil-640201
Biblioteca responsável: BR1.1
ABSTRACT

OBJECTIVE:

Anticoagulation is a challenge for the prophylaxis of thromboembolic events in elderly patients with chronic atrial fibrillation. Stable anticoagulation is defined as the time within >70% of the therapeutic range. However, the dosage required to achieve stable anticoagulation remains unknown. The aim of this study was to analyze the warfarin dose necessary for the maintenance of stable oral anticoagulation therapy in elderly patients.

METHODS:

We analyzed 112 consecutive outpatients with atrial fibrillation who were >65 years of age, had received anticoagulation therapy with warfarin for more than 1 year and had a stable international normalized ratio between 2.0 and 3.0 for >6 months. The international normalized ratio was measured in the central laboratory using the traditional method.

RESULTS:

The patients were stratified according to the following age groups <75 or >75 years and <80 or >80 years. The mean daily doses of warfarin were similar for patients <75 or >75 years (3.34+1.71 versus 3.26 +1.27 mg/ day, p = 0.794) and <80 or >80 years (3.36+ 1.49 versus 3.15 + 1.23 mg/day, p = 0.433). In 88 (79%) patients, the daily warfarin dose was between 2 and 5 mg/day; in 13 (11%) patients, the daily warfarin dose was <2.0 mg/day; and in 11 (10%) patients, the daily warfarin dose was >5.0 mg/day. The correlation between the daily warfarin dose and the international normalized ratio was 0.22 (p = 0.012).

CONCLUSION:

Stable anticoagulation was achieved in 80% of patients who received doses of 2 to 5 mg/day of warfarin, and the mean daily dose was similar across the age groups analyzed.
Assuntos


Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: LILACS Assunto principal: Fibrilação Atrial / Varfarina / Anticoagulantes Limite: Idoso / Idoso, 80 anos ou mais / Feminino / Humanos / Masculino Idioma: Inglês Revista: Clinics Assunto da revista: Medicina Ano de publicação: 2012 Tipo de documento: Artigo País de afiliação: Brasil Instituição/País de afiliação: Universidade de Sao Paulo/BR

Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: LILACS Assunto principal: Fibrilação Atrial / Varfarina / Anticoagulantes Limite: Idoso / Idoso, 80 anos ou mais / Feminino / Humanos / Masculino Idioma: Inglês Revista: Clinics Assunto da revista: Medicina Ano de publicação: 2012 Tipo de documento: Artigo País de afiliação: Brasil Instituição/País de afiliação: Universidade de Sao Paulo/BR
...